MINIPRESS 1 MG
PRAZOSIN (PRAZOSIN HYDROCHLORIDE) : 1 MG · DIN 00560952 · AA PHARMA INC
Health Canada status: DORMANT
What is MINIPRESS?
MINIPRESS 1 MG contains PRAZOSIN (PRAZOSIN HYDROCHLORIDE) : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 00560952, held by AA PHARMA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as dormant, status dated 25-Feb-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is MINIPRESS used for?
Treatment of mild to moderate essential hypertension. Used with a thiazide diuretic and/or other antihypertensive agents, or as sole therapy if other agents are inappropriate.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00560952 |
|---|---|
| Brand name | MINIPRESS |
| Generic / active ingredient | PRAZOSIN (PRAZOSIN HYDROCHLORIDE) : 1 MG |
| Manufacturer | AA PHARMA INC |
| Strength | 1 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C02CA01 PRAZOSIN |
| AHFS class | 24:20.00 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 25-Feb-2021 |
| Original market date | 1983-12-31 00:00:00 |
How is it administered?
Initial dose 0.5 mg b.i.d. or t.i.d. for 3 days, then 1 mg b.i.d. or t.i.d. for 3 days. Gradually increase to desired effect or max 20 mg/day. Take with food, preferably with evening meal.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store between 15°C to 30°C.
How is it supplied?
Bottles of 100s (all strengths), bottles of 500s (1 mg and 2 mg), and unit dose packages of 100 tablets (all strengths).
Contraindications
Known sensitivity to prazosin hydrochloride, other quinazolines, or any ingredient in the formulation.
Warnings and precautions
May cause syncope and excessive hypotension with sudden loss of consciousness (0.8% incidence). Caution with initial dose and titration. Rare reports of priapism.
What can be used instead?
Other Canadian products sharing ATC code C02CA01 PRAZOSIN. 6 of 21 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-PRAZO | 1 MG | TABLET | APOTEX INC | MARKETED | DIN 00882801 |
| APO-PRAZO | 2 MG | TABLET | APOTEX INC | MARKETED | DIN 00882828 |
| APO-PRAZO | 5 MG | TABLET | APOTEX INC | MARKETED | DIN 00882836 |
| TEVA-PRAZOSIN | 1 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 01934198 |
| TEVA-PRAZOSIN | 2 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 01934201 |
| TEVA-PRAZOSIN | 5 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 01934228 |
| ALTI-PRAZOSIN-TAB 1MG | 1 MG | TABLET | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 02139979 |
| ALTI-PRAZOSIN-TAB 2MG | 2 MG | TABLET | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 02139987 |
| ALTI-PRAZOSIN-TAB 5MG | 5 MG | TABLET | ALTIMED PHARMA INC. | CANCELLED POST MARKET | DIN 02139995 |
| MINIPRESS | 2 MG | TABLET | AA PHARMA INC | DORMANT | DIN 00560960 |
Who else supplies PRAZOSIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PRAZOSIN appears in 36 registered pack listings across 4 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.